• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在存在癌细胞球体的情况下建立和表征游离 3D 巨噬细胞编程模型。

Establishment and Characterization of Free-Floating 3D Macrophage Programming Model in the Presence of Cancer Cell Spheroids.

机构信息

Cancer Gene Therapy Group, Latvian Biomedical Research and Study Centre, Ratsupites Str. 1, k.1, LV-1067 Riga, Latvia.

出版信息

Int J Mol Sci. 2023 Jun 28;24(13):10763. doi: 10.3390/ijms241310763.

DOI:10.3390/ijms241310763
PMID:37445941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10341749/
Abstract

Reprogramming of tumor-associated macrophages (TAMs) is a promising strategy for cancer immunotherapy. Several studies have shown that cancer cells induce/support the formation of immunosuppressive TAMs phenotypes. However, the specific factors that orchestrate this immunosuppressive process are unknown or poorly studied. In vivo studies are expensive, complex, and ethically constrained. Therefore, 3D cell interaction models could become a unique framework for the identification of important TAMs programming factors. In this study, we have established and characterized a new in vitro 3D model for macrophage programming in the presence of cancer cell spheroids. First, it was demonstrated that the profile of cytokines, chemokines, and surface markers of 3D-cultured macrophages did not differ conceptually from monolayer-cultured M1 and M2-programmed macrophages. Second, the possibility of reprogramming macrophages in 3D conditions was investigated. In total, the dynamic changes in 6 surface markers, 11 cytokines, and 22 chemokines were analyzed upon macrophage programming (M1 and M2) and reprogramming (M1→M2 and M2→M1). According to the findings, the reprogramming resulted in a mixed macrophage phenotype that expressed both immunosuppressive and anti-cancer immunostimulatory features. Third, cancer cell spheroids were shown to stimulate the production of immunosuppressive M2 markers as well as pro-tumor cytokines and chemokines. In summary, the newly developed 3D model of cancer cell spheroid/macrophage co-culture under free-floating conditions can be used for studies on macrophage plasticity and for the development of targeted cancer immunotherapy.

摘要

重编程肿瘤相关巨噬细胞(TAMs)是癌症免疫治疗的一种有前途的策略。几项研究表明,癌细胞诱导/支持形成免疫抑制性 TAMs 表型。然而,协调这种免疫抑制过程的具体因素尚不清楚或研究甚少。体内研究昂贵、复杂且受到伦理限制。因此,3D 细胞相互作用模型可能成为鉴定重要 TAMs 编程因子的独特框架。在这项研究中,我们建立并表征了一种新的体外 3D 模型,用于在存在癌细胞球体的情况下对巨噬细胞进行编程。首先,证明了 3D 培养的巨噬细胞的细胞因子、趋化因子和表面标志物谱与单层培养的 M1 和 M2 编程巨噬细胞在概念上没有区别。其次,研究了在 3D 条件下重编程巨噬细胞的可能性。总共分析了 6 个表面标志物、11 个细胞因子和 22 个趋化因子在巨噬细胞编程(M1 和 M2)和重编程(M1→M2 和 M2→M1)过程中的动态变化。根据研究结果,重编程导致表达免疫抑制和抗肿瘤免疫刺激特征的混合巨噬细胞表型。第三,癌细胞球体被证明可刺激产生免疫抑制性 M2 标志物以及促肿瘤细胞因子和趋化因子。总之,新开发的癌细胞球体/巨噬细胞共培养的 3D 模型在自由浮动条件下可用于研究巨噬细胞的可塑性和开发靶向癌症免疫治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/d1848e0c9eb8/ijms-24-10763-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/86dbfca7bdb0/ijms-24-10763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/348ec801a8f6/ijms-24-10763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/57063a4a2e1f/ijms-24-10763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/1b2807622f34/ijms-24-10763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/49ccc73d2a4a/ijms-24-10763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/778564c54f0a/ijms-24-10763-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/403e67df3f8c/ijms-24-10763-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/58d27a86d47a/ijms-24-10763-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/d1848e0c9eb8/ijms-24-10763-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/86dbfca7bdb0/ijms-24-10763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/348ec801a8f6/ijms-24-10763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/57063a4a2e1f/ijms-24-10763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/1b2807622f34/ijms-24-10763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/49ccc73d2a4a/ijms-24-10763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/778564c54f0a/ijms-24-10763-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/403e67df3f8c/ijms-24-10763-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/58d27a86d47a/ijms-24-10763-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/10341749/d1848e0c9eb8/ijms-24-10763-g009.jpg

相似文献

1
Establishment and Characterization of Free-Floating 3D Macrophage Programming Model in the Presence of Cancer Cell Spheroids.在存在癌细胞球体的情况下建立和表征游离 3D 巨噬细胞编程模型。
Int J Mol Sci. 2023 Jun 28;24(13):10763. doi: 10.3390/ijms241310763.
2
Macrophage infiltration in 3D cancer spheroids to recapitulate the TME and unveil interactions within cancer cells and macrophages to modulate chemotherapeutic drug efficacy.三维肿瘤球体中的巨噬细胞浸润,以重现 TME 并揭示癌细胞和巨噬细胞之间的相互作用,从而调节化疗药物的疗效。
BMC Cancer. 2023 Dec 7;23(1):1201. doi: 10.1186/s12885-023-11674-9.
3
Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model.胰腺癌细胞/成纤维细胞共培养诱导出类似M2的巨噬细胞,其在三维模型中影响治疗反应。
PLoS One. 2017 Jul 27;12(7):e0182039. doi: 10.1371/journal.pone.0182039. eCollection 2017.
4
Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models.模拟肿瘤微环境以调节巨噬细胞表型并评估嵌入癌细胞/巨噬细胞球体模型中的化疗疗效。
Acta Biomater. 2017 Mar 1;50:271-279. doi: 10.1016/j.actbio.2016.12.037. Epub 2016 Dec 21.
5
Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.通过数学建模揭示了巨噬细胞相互作用导致的癌症纳米治疗的非线性反应,并通过 CRISPR 调节的巨噬细胞极化在小鼠模型中进行了评估。
Cancer Immunol Immunother. 2020 May;69(5):731-744. doi: 10.1007/s00262-020-02504-z. Epub 2020 Feb 8.
6
Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.无药物修饰的甘露糖基化脂质体通过促进肿瘤相关巨噬细胞的极化来抑制肿瘤生长。
Int J Nanomedicine. 2019 May 2;14:3203-3220. doi: 10.2147/IJN.S207589. eCollection 2019.
7
Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.肿瘤细胞对单核细胞/巨噬细胞极化和功能的影响以及体外桑寄生亲脂性提取物的调节潜力。
BMC Complement Altern Med. 2015 Apr 24;15:130. doi: 10.1186/s12906-015-0650-3.
8
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide.源自THP-1细胞的M1和M2巨噬细胞对癌细胞对依托泊苷的反应具有不同的调节作用。
BMC Cancer. 2015 Aug 8;15:577. doi: 10.1186/s12885-015-1546-9.
9
Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.结直肠癌来源的细胞外囊泡对单核细胞和巨噬细胞免疫表型和细胞因子分泌谱的影响。
Cell Commun Signal. 2018 Apr 24;16(1):17. doi: 10.1186/s12964-018-0229-y.
10
In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions.在无血清条件下体外生成单核细胞来源的巨噬细胞可提高其促肿瘤功能。
PLoS One. 2012;7(8):e42656. doi: 10.1371/journal.pone.0042656. Epub 2012 Aug 6.

引用本文的文献

1
Macrophage Transcriptomic Alterations Driven by Alphavirus-Based Cancer Immunotherapy Vectors.基于甲病毒的癌症免疫治疗载体驱动的巨噬细胞转录组改变
J Immunol Res. 2025 Jun 13;2025:6573891. doi: 10.1155/jimr/6573891. eCollection 2025.
2
Macrophage Polarization: Learning to Manage It 3.0.巨噬细胞极化:学会掌控它3.0
Int J Mol Sci. 2025 Jan 1;26(1):311. doi: 10.3390/ijms26010311.
3
Macrophage colony-stimulating factor and its role in the tumor microenvironment: novel therapeutic avenues and mechanistic insights.巨噬细胞集落刺激因子及其在肿瘤微环境中的作用:新的治疗途径和机制见解。

本文引用的文献

1
The Role of CXC Chemokines in Cancer Progression.CXC趋化因子在癌症进展中的作用。
Cancers (Basel). 2022 Dec 28;15(1):167. doi: 10.3390/cancers15010167.
2
Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations.用于肿瘤微环境治疗性编程的重组病毒载体:优势与局限
Biomedicines. 2022 Aug 31;10(9):2142. doi: 10.3390/biomedicines10092142.
3
CD38: A Significant Regulator of Macrophage Function.CD38:巨噬细胞功能的重要调节因子。
Front Oncol. 2024 Apr 4;14:1358750. doi: 10.3389/fonc.2024.1358750. eCollection 2024.
4
Styrylpyridinium Derivatives for Fluorescent Cell Imaging.用于荧光细胞成像的苯乙烯基吡啶鎓衍生物
Pharmaceuticals (Basel). 2023 Sep 4;16(9):1245. doi: 10.3390/ph16091245.
Front Oncol. 2022 Feb 17;12:775649. doi: 10.3389/fonc.2022.775649. eCollection 2022.
4
Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model.甲病毒驱动的γ干扰素(IFNg)表达抑制原位4T1乳腺癌模型中的肿瘤生长。
Vaccines (Basel). 2021 Oct 27;9(11):1247. doi: 10.3390/vaccines9111247.
5
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma.免疫细胞和肿瘤细胞来源的 CXCL10 可作为转移性黑色素瘤免疫治疗反应的标志物。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-003521.
6
Inflammation and tumor progression: signaling pathways and targeted intervention.炎症与肿瘤进展:信号通路与靶向干预。
Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi: 10.1038/s41392-021-00658-5.
7
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer.脂多糖通过核因子-κB/蜗牛/己糖激酶3信号轴加速糖酵解,从而促进结直肠癌转移。
Cancer Metab. 2021 May 12;9(1):23. doi: 10.1186/s40170-021-00260-x.
8
Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.针对肺癌中免疫抑制性巨噬细胞上的 MARCO 和 IL37R,阻断调节性 T 细胞并支持细胞毒性淋巴细胞功能。
Cancer Res. 2021 Feb 15;81(4):956-967. doi: 10.1158/0008-5472.CAN-20-1885. Epub 2020 Dec 8.
9
The CCL5/CCR5 Axis in Cancer Progression.癌症进展中的CCL5/CCR5轴
Cancers (Basel). 2020 Jul 2;12(7):1765. doi: 10.3390/cancers12071765.
10
Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer.CD11b的正变构调节作为一种对抗肺癌的新型治疗策略
Front Oncol. 2020 May 21;10:748. doi: 10.3389/fonc.2020.00748. eCollection 2020.